LifeMD, Inc. (LFMD) Tops Q2 EPS by 19c ; Offers Guidance

LifeMD, Inc. (NASDAQ: LFMD) reported Q2 EPS of $0.05, $0.19 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $35.95 million versus the consensus estimate of $35.17 million.

GUIDANCE:

LifeMD, Inc. sees Q3 2023 revenue of $37.5-38.5 million, versus the consensus of $37.31 million.

LifeMD, Inc. sees FY2023 revenue of $146-152 million, versus the consensus of $144.7 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• LifeMD to launch self-pay testosterone program with Antares Pharma